Original article can be found on Food and Drink Technology.
Botanical manufacturing pharmaceutical company, GES, has announced the completion of its world-class pharmaceutical laboratory in Cape Town, South Africa, which will serve domestic and international markets with plant extracts including cannabinoids for use in food, beverages and pharmaceuticals.
Despite the onset of the pandemic, the ambitious project raised 15 million Rand in April this year. In just six months a dedicated team of local scientists, engineers and builders have blended on and off-site work, expertly and safely project managed, to join together in the facility’s completion.
The company is now working with the South African health regulators to ensure the facility and its processes meet the exacting product safety protocols of food and medicinal grade operations.
The company will initially process South African plants including non-psychedelic variants of Cannabis into ingredients for food, beverages and nutraceuticals. Early in 2021 the company will transition to fulfil European markets for prescription-based cannabinoids.
“Our state-of-the-art facility allows us to harvest Southern Africa’s historical healing plants and turn them into world class health products for use in active foods, drinks and medicines” said Peter William Nel, founder and managing director of GES Labs. “We have already developed beneficial health products and ingredients based on Hemp CBD, Pelargonium and lion’s mane mushrooms “.
Wilco Drew, chairperson of GES Europe said: “We are ecstatic at how the team has shown the very best of South African resourcefulness to deliver in this very challenging year. South Africa now has a new world class medicinal grade production laboratory ready to offer new jobs and great products to the market”.